These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8991029)

  • 1. [Pancreatic cystic lesions of difficult diagnosis].
    Hammel P; Bernades P
    Presse Med; 1996 Nov; 25(36):1794-800. PubMed ID: 8991029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyst fluid analysis in the differential diagnosis of pancreatic cysts. A comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma.
    Lewandrowski KB; Southern JF; Pins MR; Compton CC; Warshaw AL
    Ann Surg; 1993 Jan; 217(1):41-7. PubMed ID: 8424699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts.
    Yang JM; Southern JF; Warshaw AL; Lewandrowski KB
    Am J Surg; 1996 Jan; 171(1):126-9; discussion 129-30. PubMed ID: 8554126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Alles AJ; Warshaw AL; Southern JF; Compton CC; Lewandrowski KB
    Ann Surg; 1994 Feb; 219(2):131-4. PubMed ID: 8129483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign, premalignant and malignant pancreatic cystic lesions: the pathology landscape.
    Demetter P; Verset L
    Acta Gastroenterol Belg; 2017; 80(2):293-298. PubMed ID: 29560696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic tumors of the pancreas.
    Gasslander T; Arnelo U; Albiin N; Permert J
    Dig Dis; 2001; 19(1):57-62. PubMed ID: 11385252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic lesions of the pancreas: more reliable differentiation with in situ high-resolution optical imaging?
    Iftimia N; Yoon WJ; Brugge WR
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):125-7. PubMed ID: 22375515
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of mucin-like carcinoma-associated antigen in the cyst fluid differentiates mucinous from nonmucinous pancreatic cysts.
    Sperti C; Pasquali C; Pedrazzoli S; Guolo P; Liessi G
    Am J Gastroenterol; 1997 Apr; 92(4):672-5. PubMed ID: 9128321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic lesions in the pancreas: when to watch, when to resect.
    Balcom IV JH; Fernandez-Del Castillo C; Warshaw AL
    Curr Gastroenterol Rep; 2000 Apr; 2(2):152-8. PubMed ID: 10981017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms.
    Rubin D; Warshaw AL; Southern JF; Pins M; Compton CC; Lewandrowski KB
    Surgery; 1994 Jan; 115(1):52-5. PubMed ID: 8284761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas.
    Hammel P; Levy P; Voitot H; Levy M; Vilgrain V; Zins M; Flejou JF; Molas G; Ruszniewski P; Bernades P
    Gastroenterology; 1995 Apr; 108(4):1230-5. PubMed ID: 7535275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR imaging of cystic lesions of the pancreas.
    Kalb B; Sarmiento JM; Kooby DA; Adsay NV; Martin DR
    Radiographics; 2009 Oct; 29(6):1749-65. PubMed ID: 19959519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
    J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic and ductal tumors of the pancreas: diagnosis and management.
    Scoazec JY; Vullierme MP; Barthet M; Gonzalez JM; Sauvanet A
    J Visc Surg; 2013 Apr; 150(2):69-84. PubMed ID: 23518192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis and treatment of pancreatic cystic diseases].
    Gooszen HG; Schmitz RF; Smit PC; Schipper ME; van Leeuwen MS; van Laarhoven CJ
    Ned Tijdschr Geneeskd; 1999 May; 143(18):925-30. PubMed ID: 10368706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential diagnosis of pancreatic cysts by MR imaging.
    Nishihara K; Kawabata A; Ueno T; Miyahara M; Hamanaka Y; Suzuki T
    Hepatogastroenterology; 1996; 43(9):714-20. PubMed ID: 8799419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions.
    Centeno BA; Lewandrowski KB; Warshaw AL; Compton CC; Southern JF
    Am J Clin Pathol; 1994 Apr; 101(4):483-7. PubMed ID: 8160642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis and radiological management of cystic pancreatic lesions].
    Buerke B; Heindel W; Wessling J
    Rofo; 2010 Oct; 182(10):852-60. PubMed ID: 20563956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cystic fluid chromogranin A levels in different pancreatic cystic lesions.
    Oruç N; Aydın A; Barutcuoğlu B; Aktan Ç; Nart D; Veral A
    Turk J Gastroenterol; 2015 Nov; 26(6):522-7. PubMed ID: 26510084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.
    Sperti C; Pasquali C; Guolo P; Polverosi R; Liessi G; Pedrazzoli S
    Cancer; 1996 Jul; 78(2):237-43. PubMed ID: 8673998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.